Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vision Systems was an Australian medical technology company that became a global leader in automated histopathology diagnostics through its subsidiary, Vision BioSystems. The company is best known for developing the Bond series of automated slide staining systems and the Peloris rapid tissue processor, which revolutionized laboratory workflows in cancer diagnostics. In 2006, after a high-profile bidding war between Cytyc and Danaher, the company was acquired by Danaher Corporation for approximately $520 million. Its operations and technologies were subsequently integrated into Leica Biosystems, where they remain core components of the pathology product line. The company's legacy continues through these widely used diagnostic platforms that automate immunohistochemistry and in situ hybridization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vision Systems.